Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translation machinery associated 7 homolog (TMA7) is a coiled-coil domain-containing protein implicated in cellular proliferation, migration, invasion, autophagy suppression, and apoptosis regulation, particularly in cancer cells such as laryngeal squamous cell carcinoma (LSCC)[1][3]. TMA7 is upregulated in LSCC and associated with poor prognosis, promoting cell growth and resistance to cisplatin via regulation of downstream molecules including UBA2 and the PI3K-mTOR signaling pathway[1]. Its expression is modulated by IGF2BP3-mediated m6A methylation, controlling mRNA stability and the cellular autophagic response. TMA7 interacts with UBA2, influencing SUMOylation processes and thereby affecting diverse cellular processes linked to cancer progression[1]. TMA7 is also known by several synonyms, including CCDC72 and HSPC016, and its dysfunction or dysregulation may play a role in both oncogenic and neuropsychiatric diseases[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translation machinery associated 7 homolog (TMA7).